Results 171 to 180 of about 371,957 (300)

Viral Vaccines as an Alternative to Antimicrobials: A Perspective from Swine Veterinarians on Challenges, Opportunities, and Future Directions. [PDF]

Pathogens
Li D, Zhang X, Apley MD, Gebhardt JT, Karriker L, Connor JF, Bromfield C, Lubbers B, Kittana H, Pendell D, Madera R, Muro N, Craig A, Shenkenberg B, Li Y, Wang L, Shi J.   +16 more
europepmc   +1 more source

Early type I IFN blockade improves the efficacy of viral vaccines. [PDF]

J Exp Med, 2020
Palacio N, Dangi T, Chung YR, Wang Y, Loredo-Varela JL, Zhang Z, Penaloza-MacMaster P.   +6 more
europepmc   +1 more source

Recent Advances in Virus–Host Interactions, Antiviral Bioactive Compounds, and Breeding for Disease Resistance of Porcine Epidemic Diarrhea Virus

Animal Research and One Health, EarlyView.
Basic research on the PEDV infection cycle and virus–host interactions advances the development of anti‐PEDV drugs and disease‐resistant breeding and helps strengthen disease prevention and control while reducing economic losses in the swine industry.
Heyong Wu, Aosi Qi, Shuyu Zhong, Haozhen Du, Shimeng Guo, Hongsheng Ouyang, Hongming Yuan, Daxin Pang, Zicong Xie   +8 more
wiley   +1 more source

Artificial Intelligence Driven Framework for the Design and Development of Next-Generation Avian Viral Vaccines. [PDF]

Microorganisms
Goud MD, Ramos E, Shah AU, Hemida MG.
europepmc   +1 more source

Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines. [PDF]

Vaccines (Basel), 2020
Serwer P.
europepmc   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Bibliometric analysis of global research output on viral vaccines and antivirals in the 21st century. [PDF]

Virol Sin
Ma L, Pan W, Yan M, Si J.
europepmc   +1 more source

Harnessing co-operative immune augmentation by contact allergens to enhance the efficacy of viral vaccines. [PDF]

Contact Dermatitis, 2020
Cunningham LS, McFadden JP, Basketter DA, Ferguson FJ, White IR, Kimber I.   +5 more
europepmc   +1 more source

Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel, Christine van Linge, W. Joost Wiersinga, Ilse J. E. Kouijzer, Quirijn de Mast, Robert‐Jan Hassing, Danique J. H. Huijbens, Helen L. Leavis, Roger Schutgens, Coen Maas, Kit C. B. Roes, Frank L. van de Veerdonk, Roger Brüggemann   +12 more
wiley   +1 more source

The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia. [PDF]

Front Immunol, 2020
Vakkilainen S, Kleino I, Honkanen J, Salo H, Kainulainen L, Gräsbeck M, Kekäläinen E, Mäkitie O, Klemetti P.   +8 more
europepmc   +1 more source